Literature DB >> 20722970

Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex.

Wei Si1, Leah Aluisio, Naoe Okamura, Stewart D Clark, Ian Fraser, Steven W Sutton, Pascal Bonaventure, Rainer K Reinscheid.   

Abstract

Neuropeptide S (NPS) is known to produce anxiolytic-like effects and facilitate extinction of conditioned fear. Catecholaminergic neurotransmission in the medial prefrontal cortex (mPFC) has been suggested to be crucially involved in these brain functions. In the current study, we investigated the effect of NPS on the release of dopamine and serotonin in the mPFC by in vivo microdialysis in rats. Central administration of NPS dose-dependently enhanced extracellular levels of dopamine and its major metabolite 3,4-dihydroxyphenylacetic acid, with maximal effects lasting up to 120 min. In contrast, no effect on serotonergic neurotransmission was detected. Dopamine release in the mPFC has been previously linked to modulation of anxiety states and fear extinction. The present results may thus provide a physiological and anatomical basis for the reported effects of NPS on these behaviors.
© 2010 The Authors. Journal Compilation © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722970      PMCID: PMC2970681          DOI: 10.1111/j.1471-4159.2010.06947.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  55 in total

1.  Prefrontal cortex long-term potentiation, but not long-term depression, is associated with the maintenance of extinction of learned fear in mice.

Authors:  Cyril Herry; Rene Garcia
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

2.  Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68.

Authors:  Chiara Ruzza; Anna Rizzi; Claudio Trapella; Michela Pela'; Valeria Camarda; Valentina Ruggieri; Monica Filaferro; Carlo Cifani; Rainer K Reinscheid; Giovanni Vitale; Roberto Ciccocioppo; Severo Salvadori; Remo Guerrini; Girolamo Calo'
Journal:  Peptides       Date:  2010-02-19       Impact factor: 3.750

Review 3.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

Review 4.  Prefrontal cortical regulation of hypothalamic-pituitary-adrenal function in the rat and implications for psychopathology: side matters.

Authors:  Ron M Sullivan; Alain Gratton
Journal:  Psychoneuroendocrinology       Date:  2002 Jan-Feb       Impact factor: 4.905

5.  Intra-amygdala injections of neuropeptide S block fear-potentiated startle.

Authors:  Markus Fendt; Stefan Imobersteg; Hugo Bürki; Kevin H McAllister; Andreas W Sailer
Journal:  Neurosci Lett       Date:  2010-03-15       Impact factor: 3.046

6.  Prevention of the stress-induced increase in frontal cortical dopamine efflux of freely moving rats by long-term treatment with antidepressant drugs.

Authors:  L Dazzi; M Serra; F Spiga; M G Pisu; J D Jentsch; G Biggio
Journal:  Eur Neuropsychopharmacol       Date:  2001-10       Impact factor: 4.600

7.  Microinjection of neuropeptide S into the rat ventral tegmental area induces hyperactivity and increases extracellular levels of dopamine metabolites in the nucleus accumbens shell.

Authors:  Takahiro Mochizuki; Juhyon Kim; Kazuo Sasaki
Journal:  Peptides       Date:  2010-02-13       Impact factor: 3.750

8.  Sustained conditioned responses in prelimbic prefrontal neurons are correlated with fear expression and extinction failure.

Authors:  Anthony Burgos-Robles; Ivan Vidal-Gonzalez; Gregory J Quirk
Journal:  J Neurosci       Date:  2009-07-01       Impact factor: 6.167

9.  Behavioral phenotyping of neuropeptide S receptor knockout mice.

Authors:  Dee M Duangdao; Stewart D Clark; Naoe Okamura; Rainer K Reinscheid
Journal:  Behav Brain Res       Date:  2009-07-29       Impact factor: 3.332

10.  Dopamine D1 versus D4 receptors differentially modulate the encoding of salient versus nonsalient emotional information in the medial prefrontal cortex.

Authors:  Nicole M Lauzon; Stephanie F Bishop; Steven R Laviolette
Journal:  J Neurosci       Date:  2009-04-15       Impact factor: 6.167

View more
  20 in total

1.  Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons.

Authors:  Irina A Ionescu; Julien Dine; Yi-Chun Yen; Dominik R Buell; Leonie Herrmann; Florian Holsboer; Matthias Eder; Rainer Landgraf; Ulrike Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

2.  Activation of neuropeptide S-expressing neurons in the locus coeruleus by corticotropin-releasing factor.

Authors:  Kay Jüngling; Xiaobin Liu; Jörg Lesting; Philippe Coulon; L Sosulina; Rainer K Reinscheid; Hans-Christian Pape
Journal:  J Physiol       Date:  2012-05-08       Impact factor: 5.182

3.  Identification of neuropeptide S antagonists: structure-activity relationship studies, X-ray crystallography, and in vivo evaluation.

Authors:  Carla Hassler; Yanan Zhang; Brian Gilmour; Tyler Graf; Timothy Fennell; Rodney Snyder; Jeffrey R Deschamps; Rainer K Reinscheid; Celia Garau; Scott P Runyon
Journal:  ACS Chem Neurosci       Date:  2014-07-11       Impact factor: 4.418

Review 4.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

Review 5.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

Review 6.  Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.

Authors:  Jesse R Schank; Andrey E Ryabinin; William J Giardino; Roberto Ciccocioppo; Markus Heilig
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

7.  Neuroleptics Affect Neuropeptide S and NPSR mRNA Levels in the Rat Brain.

Authors:  Artur Pałasz; Ewa Rojczyk
Journal:  J Mol Neurosci       Date:  2015-07-31       Impact factor: 3.444

Review 8.  Translational approach to develop novel medications on alcohol addiction: focus on neuropeptides.

Authors:  Massimo Ubaldi; Angelo Bifone; Roberto Ciccocioppo
Journal:  Curr Opin Neurobiol       Date:  2013-05-03       Impact factor: 6.627

Review 9.  Can fear extinction be enhanced? A review of pharmacological and behavioral findings.

Authors:  Paul J Fitzgerald; Jocelyn R Seemann; Stephen Maren
Journal:  Brain Res Bull       Date:  2013-12-25       Impact factor: 4.077

Review 10.  Pharmacology, Physiology and Genetics of the Neuropeptide S System.

Authors:  Rainer K Reinscheid; Chiara Ruzza
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.